Create Alert
Watchlist

Orchid Pharma

₹0.00
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All

Performance

Open
0.00
Prev. Close
0.00
Volume
NA
Total traded value
NA
Upper Circuit
NA
Lower Circuit
NA

Fundamentals

Market Cap₹3,640Cr
ROE7.86%
P/E Ratio(TTM)36.52
EPS(TTM)19.65
P/B Ratio2.87
Dividend Yield0.00%
Industry P/E35.17
Book Value249.86
Debt to Equity0.14
Face Value10
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Orchid Pharma

Orchid Pharma Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of integrated active pharmaceutical ingredients (API). It operates through the pharmaceutical segment. It has a multi-therapeutic presence across segments like anti-infectives, anti-inflammatory, central nervous system (CNS), cardiovascular segment (CVS), nutraceuticals and other oral and sterile products. Its pharmaceutical solutions include active pharmaceutical ingredients (APIs) and finished dosage forms. It offers APIs, including Cephalosporins-Orals, Cephalosporins-Injectables, Veterinary Products and Non-Antibodies. Its formulations include Cefixime Capsules, Acarbose Tablets, Acarbose Tablets, Clozapime Tablets, Clopidogrel Tablets, Desloratadine Tablets and Cefoperazone and Sulbactam for Injection, among others. Its subsidiaries include Orchid Europe Limited, Orchid Pharmaceuticals Inc., Bexel Pharmaceuticals Inc., and Diakron Pharmaceuticals, Inc., among others.;
Parent OrganisationOrchid Pharma
Managing DirectorShri. Manish Dhanuka
NSE SymbolORCHPHARMA

Shareholding Pattern

Mar '24
Jun '24
Sep '24
Dec '24
Mar '25
Promoters
69.84%
Mutual Funds
18.79%
Retail And Others
7.38%
Foreign Institutions
2.69%
Other Domestic Institutions
1.31%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Cohance Lifesciences
NA
(0.00%)
145.99
Wockhardt
NA
(0.00%)
-2373.99
JB Chemicals & Pharmaceuticals
NA
(0.00%)
38.06
Emcure Pharmaceuticals
NA
(0.00%)
36.07